calendar
4,366 catalysts · 3,045 8k filing · 571 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
4,366 catalysts · 3,045 8k filing · 571 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL
Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL
Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: CIPLA. Form: CAPSULE. Route: ORAL
Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL
Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL
Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: CAPSULE. Route: ORAL
Product code: GEH. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: PHC. Advisory committee: General Hospital. Type: Traditional
Product code: HSX. Advisory committee: Orthopedic. Type: Special
Product code: KPE. Advisory committee: General Hospital. Type: Traditional
Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional
Product code: IRP. Advisory committee: Physical Medicine. Type: Traditional
Product code: PBX. Advisory committee: General, Plastic Surgery. Type: Special
Product code: QBV. Advisory committee: Clinical Chemistry. Type: Traditional
Product code: SEP. Advisory committee: Microbiology. Type: Traditional
Product code: QBV. Advisory committee: Clinical Chemistry. Type: Traditional
Product code: IYN. Advisory committee: Radiology. Type: Traditional
Product code: JEY. Advisory committee: Dental. Type: Traditional
Product code: FOZ. Advisory committee: General Hospital. Type: Traditional
Product code: NQD. Advisory committee: Immunology. Type: Traditional
Product code: OWB. Advisory committee: Radiology. Type: Traditional
Supplement type: 30-Day Notice. Product code: NUU. Advisory committee: OP. Decision: OK30
Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30
Supplement type: Real-Time Process. Product code: QVG. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track. Product code: MAQ. Advisory committee: MI. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: MAQ. Advisory committee: MI. Decision: APPR
Supplement type: 30-Day Notice. Product code: NIO. Advisory committee: CV. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: NVN. Advisory committee: CV. Decision: APPR
Product code: SDZ. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: QZI. Advisory committee: CV. Decision: OK30
CA grant. $482,312. PI: Wei Hu
CA grant. $442,816. PI: Hussein Abbas
AI grant. $430,375. PI: Victoria Auerbuch Stone
CA grant. $608,558. PI: Ruoning Wang
AI grant. $159,300. PI: Sydney Ilima Ramirez
AI grant. $164,000. PI: Axel Rolando Concepcion Gonzalez
AI grant. $158,800. PI: Karthik Hullahalli
AR grant. $582,695. PI: Jill P Buyon
MH grant. $126,900. PI: Lynn Yap
AI grant. $818,457. PI: Erin June Adams
AI grant. $194,160. PI: Ian Alexander Mellis
AI grant. $161,946. PI: Katherine Owens
AI grant. $561,410. PI: Crista Burke Wadsworth
CA grant. $646,181. PI: Janghee Woo